The combination therapy lets patients take a single pill once a day for treatment, which leads to improved adherence. Results of the study were presented at the Academy of Managed Care Pharmacy Nexus ...
Data presented at HIV Glasgow from the DOLCE study demonstrates our commitment to offering effective 2-drug HIV regimens, for people living with advanced HIV A post-hoc analysis shows the 2-drug ...
(HealthDay)—For patients with HIV-1 infection and HIV-1 RNA of 1,000 copies per mL or more, treatment with dolutegravir plus abacavir-lamivudine (DTG-ABC-3TC) is more effective through 48 weeks than ...
Second-line treatment with dolutegravir and recycled nucleoside reverse transcriptase inhibitors (NRTIs) tenofovir and lamivudine was superior to protease inhibitor (PI)-based treatment using a new ...
The two-drug regimen dolutegravir/lamivudine (DTG/3TC; Dovato) was just as effective as the three-drug regimen bictegravir/emtricitabine/tenofovir alafenamide ...
In the early days of the HIV pandemic, many people with the infection wasted away, unable to absorb their food properly. Today, with ARV treatment for the disease being so effective, this should never ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results